Tissue Factor, Lipid Rafts, and Microparticles

 

 Buy Article Permissions and Reprints

ABSTRACT

Evidence is emerging that tissue-factor–bearing microparticles and other microparticles arise from regions of the parent cell's plasma membrane that are rich in lipid rafts. In this brief review, we summarize the evidence for the raft origins of microparticles and the implications of these origins for the biological and medical consequences of microparticle production and for therapeutic strategies to diminish their production and potential to do harm.

REFERENCES

• 1 Ruf W, Furlan-Freguia C, Niessen F. Vascular and dendritic cell coagulation signaling in sepsis progression.  J Thromb Haemost. 2009;  7(Suppl 1) 118-121
  CrossrefPubMedGoogle Scholar
• 2 Morris D R, Ding Y, Ricks T K, Gullapalli A, Wolfe B L, Trejo J. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.  Cancer Res. 2006;  66(1) 307-314
  CrossrefPubMedGoogle Scholar
• 3 Riewald M, Ruf W. Orchestration of coagulation protease signaling by tissue factor.  Trends Cardiovasc Med. 2002;  12(4) 149-154
  CrossrefPubMedGoogle Scholar
• 4 Hembrough T A, Swartz G M, Papathanassiu A et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.  Cancer Res. 2003;  63(11) 2997-3000
  Google Scholar
• 5 Khorana A A, Ahrendt S A, Ryan C K et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.  Clin Cancer Res. 2007;  13(10) 2870-2875
  CrossrefPubMedGoogle Scholar
• 6 De Blaineville H MD. Injection de matière cérébrale dans des veines.  Gazette Medical Paris. 1834;  2 524
  PubMedGoogle Scholar
• 7 Morawitz P. Die Chemie der Blutgerinnung.  Ergeb Physiol. 1905;  4 307-422
  PubMedGoogle Scholar
• 8 Howell W H. Theories of blood coagulation.  Physiol Rev. 1935;  15 435-470
  PubMedGoogle Scholar
• 9 Bächli E. History of tissue factor.  Br J Haematol. 2000;  110(2) 248-255
  CrossrefPubMedGoogle Scholar
• 10 Broze Jr G J, Leykam J E, Schwartz B D, Miletich J P. Purification of human brain tissue factor.  J Biol Chem. 1985;  260(20) 10917-10920
  PubMedGoogle Scholar
• 11 Fisher K L, Gorman C M, Vehar G A, O'Brien D P, Lawn R M. Cloning and expression of human tissue factor cDNA.  Thromb Res. 1987;  48(1) 89-99
  CrossrefPubMedGoogle Scholar
• 12 Morrissey J H, Fakhrai H, Edgington T S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade.  Cell. 1987;  50(1) 129-135
  CrossrefPubMedGoogle Scholar
• 13 Scarpati E M, Wen D, Broze Jr G J et al. Human tissue factor: cDNA sequence and chromosome localization of the gene.  Biochemistry. 1987;  26(17) 5234-5238
  CrossrefPubMedGoogle Scholar
• 14 Spicer E K, Horton R, Bloem L et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA.  Proc Natl Acad Sci U S A. 1987;  84(15) 5148-5152
  CrossrefPubMedGoogle Scholar
• 15 Mackman N, Morrissey J H, Fowler B, Edgington T S. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade.  Biochemistry. 1989;  28(4) 1755-1762
  CrossrefPubMedGoogle Scholar
• 16 Edgington T S, Ruf W, Rehemtulla A, Mackman N. The molecular biology of initiation of coagulation by tissue factor.  Curr Stud Hematol Blood Transfus. 1991;  (58) 15-21
  PubMedGoogle Scholar
• 17 Morrissey J H, Gregory S A, Mackman N, Edgington T S. Tissue factor regulation and gene organization.  Oxf Surv Eukaryot Genes. 1989;  6 67-84
  PubMedGoogle Scholar
• 18 Chen V M, Ahamed J, Versteeg H H, Berndt M C, Ruf W, Hogg P J. Evidence for activation of tissue factor by an allosteric disulfide bond.  Biochemistry. 2006;  45(39) 12020-12028
  CrossrefPubMedGoogle Scholar
• 19 Dorfleutner A, Ruf W. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation.  Blood. 2003;  102(12) 3998-4005
  CrossrefPubMedGoogle Scholar
• 20 Bach R, Konigsberg W H, Nemerson Y. Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine.  Biochemistry. 1988;  27(12) 4227-4231
  CrossrefPubMedGoogle Scholar
• 21 Drake T A, Morrissey J H, Edgington T S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.  Am J Pathol. 1989;  134(5) 1087-1097
  PubMedGoogle Scholar
• 22 Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development.  Arterioscler Thromb Vasc Biol. 2004;  24(6) 1015-1022
  CrossrefPubMedGoogle Scholar
• 23 Furie B, Furie B C. Mechanisms of thrombus formation.  N Engl J Med. 2008;  359(9) 938-949
  CrossrefPubMedGoogle Scholar
• 24 Giesen P L, Rauch U, Bohrmann B et al. Blood-borne tissue factor: another view of thrombosis.  Proc Natl Acad Sci U S A. 1999;  96(5) 2311-2315
  CrossrefPubMedGoogle Scholar
• 25 Del Conde I, Bharwani L D, Dietzen D J, Pendurthi U, Thiagarajan P, López J A. Microvesicle-associated tissue factor and Trousseau's syndrome.  J Thromb Haemost. 2007;  5(1) 70-74
  Google Scholar
• 26 Bogdanov V Y, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.  Nat Med. 2003;  9(4) 458-462
  Google Scholar
• 27 Nawroth P P, Stern D M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor.  J Exp Med. 1986;  163(3) 740-745
  CrossrefPubMedGoogle Scholar
• 28 Norris L A, Weldon S, Nugent A, Roche H M. LPS induced tissue factor expression in the THP-1 monocyte cell line is attenuated by conjugated linoleic acid.  Thromb Res. 2006;  117(4) 475-480
  CrossrefPubMedGoogle Scholar
• 29 Bevilacqua M P, Pober J S, Majeau G R, Fiers W, Cotran R S, Gimbrone Jr M A. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.  Proc Natl Acad Sci U S A. 1986;  83(12) 4533-4537
  CrossrefPubMedGoogle Scholar
• 30 Gerrits A J, Koekman C A, van Haeften T W, Akkerman J W. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin.  Diabetes. 2010;  59(6) 1487-1495
  CrossrefPubMedGoogle Scholar
• 31 Egorina E M, Sovershaev M A, Olsen J O, Østerud B. Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer.  Blood. 2008;  111(3) 1208-1216
  CrossrefPubMedGoogle Scholar
• 32 Bach R R. Tissue factor encryption.  Arterioscler Thromb Vasc Biol. 2006;  26(3) 456-461
  CrossrefPubMedGoogle Scholar
• 33 Ahamed J, Versteeg H H, Kerver M et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling.  Proc Natl Acad Sci U S A. 2006;  103(38) 13932-13937
  CrossrefPubMedGoogle Scholar
• 34 Toomey J R, Kratzer K E, Lasky N M, Stanton J J, Broze Jr G J. Targeted disruption of the murine tissue factor gene results in embryonic lethality.  Blood. 1996;  88(5) 1583-1587
  PubMedGoogle Scholar
• 35 Parry G C, Erlich J H, Carmeliet P, Luther T, Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice.  J Clin Invest. 1998;  101(3) 560-569
  CrossrefPubMedGoogle Scholar
• 36 Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression.  J Biol Chem. 2000;  275(9) 6580-6585
  CrossrefPubMedGoogle Scholar
• 37 Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle.  Science. 2010;  327(5961) 46-50
  CrossrefPubMedGoogle Scholar
• 38 Goswami D, Gowrishankar K, Bilgrami S et al. Nanoclusters of GPI-anchored proteins are formed by cortical actin-driven activity.  Cell. 2008;  135(6) 1085-1097
  CrossrefPubMedGoogle Scholar
• 39 Davizon P, López J A. Microparticles and thrombotic disease.  Curr Opin Hematol. 2009;  16(5) 334-341
  CrossrefPubMedGoogle Scholar
• 40 Ueba T, Nomura S, Inami N et al. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men.  J Atheroscler Thromb. 2010;  17(4) 342-349
  CrossrefPubMedGoogle Scholar
• 41 Flaumenhaft R, Dilks J R, Richardson J et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles.  Blood. 2009;  113(5) 1112-1121
  CrossrefPubMedGoogle Scholar
• 42 Berckmans R J, Neiuwland R, Böing A N, Romijn F P, Hack C E, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation.  Thromb Haemost. 2001;  85(4) 639-646
  PubMedGoogle Scholar
• 43 Habib A, Kunzelmann C, Shamseddeen W, Zobairi F, Freyssinet J M, Taher A. Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia.  Haematologica. 2008;  93(6) 941-942
  CrossrefPubMedGoogle Scholar
• 44 Fontana V, Jy W, Ahn E R et al. Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP.  Thromb Res. 2008;  122(5) 599-603
  CrossrefPubMedGoogle Scholar
• 45 Chironi G N, Simon A, Boulanger C M et al. Circulating microparticles may influence early carotid artery remodeling.  J Hypertens. 2010;  28(4) 789-796
  CrossrefPubMedGoogle Scholar
• 46 Nomura S, Shouzu A, Omoto S et al. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes.  J Atheroscler Thromb. 2009;  16(2) 83-90
  CrossrefPubMedGoogle Scholar
• 47 Ueba T, Haze T, Sugiyama M et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome.  Thromb Haemost. 2008;  100(2) 280-285
  PubMedGoogle Scholar
• 48 Boilard E, Nigrovic P A, Larabee K et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.  Science. 2010;  327(5965) 580-583
  CrossrefPubMedGoogle Scholar
• 49 Del Conde I, Shrimpton C N, Thiagarajan P, López J A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.  Blood. 2005;  106(5) 1604-1611
  CrossrefPubMedGoogle Scholar
• 50 Dietzen D J, Page K L, Tetzloff T A. Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity.  Blood. 2004;  103(8) 3038-3044
  CrossrefPubMedGoogle Scholar
• 51 Pendurthi U R, Ghosh S, Mandal S K, Rao L V. Tissue factor activation: is disulfide bond switching a regulatory mechanism?.  Blood. 2007;  110(12) 3900-3908
  CrossrefPubMedGoogle Scholar
• 52 Biró E, Akkerman J W, Hoek F J et al. The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions.  J Thromb Haemost. 2005;  3(12) 2754-2763
  CrossrefPubMedGoogle Scholar
• 53 Wong S W, Kwon M J, Choi A M, Kim H P, Nakahira K, Hwang D H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner.  J Biol Chem. 2009;  284(40) 27384-27392
  CrossrefPubMedGoogle Scholar
• 54 Carter G C, Bernstone L, Sangani D, Bee J W, Harder T, James W. HIV entry in macrophages is dependent on intact lipid rafts.  Virology. 2009;  386(1) 192-202
  CrossrefPubMedGoogle Scholar
• 55 Chen Y, Ott C J, Townsend K, Subbaiah P, Aiyar A, Miller W M. Cholesterol supplementation during production increases the infectivity of retroviral and lentiviral vectors pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G).  Biochem Eng J. 2009;  44(2-3) 199-207
  CrossrefPubMedGoogle Scholar
• 56 Nguyen D H, Hildreth J E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.  J Virol. 2000;  74(7) 3264-3272
  CrossrefPubMedGoogle Scholar
• 57 Scheiffele P, Rietveld A, Wilk T, Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane.  J Biol Chem. 1999;  274(4) 2038-2044
  CrossrefPubMedGoogle Scholar
• 58 Takeda M, Leser G P, Russell C J, Lamb R A. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion.  Proc Natl Acad Sci U S A. 2003;  100(25) 14610-14617
  CrossrefPubMedGoogle Scholar
• 59 Scolari S, Engel S, Krebs N et al. Lateral distribution of the transmembrane domain of influenza virus hemagglutinin revealed by time-resolved fluorescence imaging.  J Biol Chem. 2009;  284(23) 15708-15716
  CrossrefPubMedGoogle Scholar
• 60 Isa P, Realpe M, Romero P, López S, Arias C F. Rotavirus RRV associates with lipid membrane microdomains during cell entry.  Virology. 2004;  322(2) 370-381
  CrossrefPubMedGoogle Scholar
• 61 Bitler A, Lev N, Fridmann-Sirkis Y, Blank L, Cohen S R, Shai Y. Kinetics of interaction of HIV fusion protein (gp41) with lipid membranes studied by real-time AFM imaging.  Ultramicroscopy. 2010;  110(6) 694-700
  CrossrefPubMedGoogle Scholar
• 62 Coil D A, Miller A D. Enhancement of enveloped virus entry by phosphatidylserine.  J Virol. 2005;  79(17) 11496-11500
  CrossrefPubMedGoogle Scholar
• 63 Patil A, Gautam A, Bhattacharya J. Evidence that Gag facilitates HIV-1 envelope association both in GPI-enriched plasma membrane and detergent resistant membranes and facilitates envelope incorporation onto virions in primary CD4 + T cells.  Virol J. 2010;  7 3
  CrossrefPubMedGoogle Scholar
• 64 Li H, Dou J, Ding L, Spearman P. Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells.  J Virol. 2007;  81(23) 12899-12910
  CrossrefPubMedGoogle Scholar
• 65 Adamson C S, Freed E O. Human immunodeficiency virus type 1 assembly, release, and maturation.  Adv Pharmacol. 2007;  55 347-387
  PubMedGoogle Scholar
• 66 Christersson C, Johnell M, Siegbahn A. Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10.  J Thromb Haemost. 2008;  6(6) 986-994
  CrossrefPubMedGoogle Scholar
• 67 Liu M L, Reilly M P, Casasanto P, McKenzie S E, Williams K J. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.  Arterioscler Thromb Vasc Biol. 2007;  27(2) 430-435
  CrossrefPubMedGoogle Scholar
• 68 Becker L, Gharib S A, Irwin A D et al. A macrophage sterol-responsive network linked to atherogenesis.  Cell Metab. 2010;  11(2) 125-135
  CrossrefPubMedGoogle Scholar
• 69 Nomura S, Inami N, Shouzu A et al. The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.  Platelets. 2009;  20(1) 16-22
  CrossrefPubMedGoogle Scholar
• 70 Dietzen D J, Page K L, Tetzloff T A, Bohrer A, Turk J. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase blunts factor VIIa/tissue factor and prothrombinase activities via effects on membrane phosphatidylserine.  Arterioscler Thromb Vasc Biol. 2007;  27(3) 690-696
  CrossrefPubMedGoogle Scholar
• 71 Jeon J Y, Hwang S Y, Cho S H, Choo J, Lee E K. Effect of cholesterol content on affinity and stability of factor VIII and annexin V binding to a liposomal bilayer membrane.  Chem Phys Lipids. 2010;  163(4–5) 335-340
  CrossrefPubMedGoogle Scholar
• 72 Jump D B. The biochemistry of n-3 polyunsaturated fatty acids.  J Biol Chem. 2002;  277(11) 8755-8758
  CrossrefPubMedGoogle Scholar
• 73 Shaikh S R, Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation.  Am J Clin Nutr. 2006;  84(6) 1277-1289
  PubMedGoogle Scholar
• 74 Pruemer J. Prevalence, causes, and impact of cancer-associated thrombosis.  Am J Health Syst Pharm. 2005;  62(22, Suppl 5) S4-S6
  PubMedGoogle Scholar
• 75 López J A, Chen J. Pathophysiology of venous thrombosis.  Thromb Res. 2009;  123(Suppl 4) S30-S34
  PubMedGoogle Scholar
• 76 Yu J L, Rak J W. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells.  J Thromb Haemost. 2004;  2(11) 2065-2067
  Google Scholar
• 77 Tateo S, Mereu L, Salamano S et al. Ovarian cancer and venous thromboembolic risk.  Gynecol Oncol. 2005;  99(1) 119-125
  CrossrefPubMedGoogle Scholar
• 78 Iodice S, Gandini S, Löhr M, Lowenfels A B, Maisonneuve P. Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis.  J Thromb Haemost. 2008;  6(5) 781-788
  CrossrefPubMedGoogle Scholar
• 79 Sato T, Tsujino I, Ikeda D, Ieko M, Nishimura M. Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma.  Thorax. 2006;  61(11) 1009-1010
  CrossrefPubMedGoogle Scholar
• 80 Davila M, Amirkhosravi A, Coll E et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation.  J Thromb Haemost. 2008;  6(9) 1517-1524
  CrossrefPubMedGoogle Scholar
• 81 Regina S, Valentin J B, Lachot S, Lemarié E, Rollin J, Gruel Y. Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN.  Clin Chem. 2009;  55(10) 1834-1842
  CrossrefPubMedGoogle Scholar
• 82 Yokota N, Koizume S, Miyagi E et al. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.  Br J Cancer. 2009;  101(12) 2023-2029
  CrossrefPubMedGoogle Scholar
• 83 Versteeg H H, Schaffner F, Kerver M et al. Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.  Cancer Res. 2008;  68(17) 7219-7227
  CrossrefPubMedGoogle Scholar
• 84 Schaffner F, Ruf W. Tissue factor and PAR2 signaling in the tumor microenvironment.  Arterioscler Thromb Vasc Biol. 2009;  29(12) 1999-2004
  CrossrefPubMedGoogle Scholar

José A LópezM.D. 

Research Division, Puget Sound Blood Center

921 Terry Avenue, Seattle, WA 98104

Email: josel@psbcresearch.org